Lemaitre Vascular (LMAT) EBIAT (2016 - 2025)
Historic EBIAT for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $17.4 million.
- Lemaitre Vascular's EBIAT rose 5583.88% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 million, marking a year-over-year increase of 2908.35%. This contributed to the annual value of $44.0 million for FY2024, which is 4628.13% up from last year.
- Latest data reveals that Lemaitre Vascular reported EBIAT of $17.4 million as of Q3 2025, which was up 5583.88% from $13.8 million recorded in Q2 2025.
- Over the past 5 years, Lemaitre Vascular's EBIAT peaked at $17.4 million during Q3 2025, and registered a low of $3.5 million during Q2 2022.
- Its 5-year average for EBIAT is $8.6 million, with a median of $8.1 million in 2023.
- In the last 5 years, Lemaitre Vascular's EBIAT surged by 13711.43% in 2021 and then plummeted by 5764.55% in 2022.
- Lemaitre Vascular's EBIAT (Quarter) stood at $6.2 million in 2021, then dropped by 8.87% to $5.6 million in 2022, then skyrocketed by 50.44% to $8.5 million in 2023, then surged by 32.12% to $11.2 million in 2024, then skyrocketed by 55.24% to $17.4 million in 2025.
- Its EBIAT was $17.4 million in Q3 2025, compared to $13.8 million in Q2 2025 and $11.0 million in Q1 2025.